Zhejiang Lante Optics Balance Sheet Health

Financial Health criteria checks 5/6

Zhejiang Lante Optics has a total shareholder equity of CN¥1.6B and total debt of CN¥114.3M, which brings its debt-to-equity ratio to 7.1%. Its total assets and total liabilities are CN¥2.1B and CN¥481.6M respectively. Zhejiang Lante Optics's EBIT is CN¥219.1M making its interest coverage ratio -35.7. It has cash and short-term investments of CN¥208.6M.

Key information

7.1%

Debt to equity ratio

CN¥114.29m

Debt

Interest coverage ratio	-35.7x
Cash	CN¥208.64m
Equity	CN¥1.62b
Total liabilities	CN¥481.58m
Total assets	CN¥2.10b

Recent financial health updates

Does Zhejiang Lante Optics (SHSE:688127) Have A Healthy Balance Sheet?

Jun 26

Recent updates

A Look At The Intrinsic Value Of Zhejiang Lante Optics Co., Ltd. (SHSE:688127)

Sep 27

Investors Shouldn't Be Too Comfortable With Zhejiang Lante Optics' (SHSE:688127) Earnings

Sep 02

Subdued Growth No Barrier To Zhejiang Lante Optics Co., Ltd.'s (SHSE:688127) Price

Jul 31

Capital Allocation Trends At Zhejiang Lante Optics (SHSE:688127) Aren't Ideal

Jul 14

Does Zhejiang Lante Optics (SHSE:688127) Have A Healthy Balance Sheet?

Jun 26

Does This Valuation Of Zhejiang Lante Optics Co., Ltd. (SHSE:688127) Imply Investors Are Overpaying?

May 21

Here's What's Concerning About Zhejiang Lante Optics' (SHSE:688127) Returns On Capital

Mar 28

Why Investors Shouldn't Be Surprised By Zhejiang Lante Optics Co., Ltd.'s (SHSE:688127) 30% Share Price Surge

Mar 07

Financial Position Analysis

Short Term Liabilities: 688127's short term assets (CN¥640.1M) exceed its short term liabilities (CN¥374.4M).

Long Term Liabilities: 688127's short term assets (CN¥640.1M) exceed its long term liabilities (CN¥107.1M).

Debt to Equity History and Analysis

Debt Level: 688127 has more cash than its total debt.

Reducing Debt: 688127's debt to equity ratio has increased from 2.4% to 7.1% over the past 5 years.

Debt Coverage: 688127's debt is well covered by operating cash flow (312.4%).

Interest Coverage: 688127 earns more interest than it pays, so coverage of interest payments is not a concern.

Zhejiang Lante Optics Balance Sheet Health

Financial Health criteria checks 5/6

Key information

Recent financial health updates

Does Zhejiang Lante Optics (SHSE:688127) Have A Healthy Balance Sheet?

Recent updates

A Look At The Intrinsic Value Of Zhejiang Lante Optics Co., Ltd. (SHSE:688127)

Now 20% undervalued after recent price drop

Investors Shouldn't Be Too Comfortable With Zhejiang Lante Optics' (SHSE:688127) Earnings

Second quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.036 in 2Q 2023)

Subdued Growth No Barrier To Zhejiang Lante Optics Co., Ltd.'s (SHSE:688127) Price

New minor risk - Share price stability

Now 25% overvalued after recent price rise

Capital Allocation Trends At Zhejiang Lante Optics (SHSE:688127) Aren't Ideal

Investor sentiment improves as stock rises 19%

Zhejiang Lante Optics Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Does Zhejiang Lante Optics (SHSE:688127) Have A Healthy Balance Sheet?

Now 22% overvalued

Does This Valuation Of Zhejiang Lante Optics Co., Ltd. (SHSE:688127) Imply Investors Are Overpaying?

Now 24% overvalued

First quarter 2024 earnings released: EPS: CN¥0.07 (vs CN¥0.012 in 1Q 2023)

Zhejiang Lante Optics Co., Ltd., Annual General Meeting, May 16, 2024

Zhejiang Lante Optics Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Here's What's Concerning About Zhejiang Lante Optics' (SHSE:688127) Returns On Capital

Why Investors Shouldn't Be Surprised By Zhejiang Lante Optics Co., Ltd.'s (SHSE:688127) 30% Share Price Surge

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 15%

New minor risk - Share price stability

Investor sentiment improves as stock rises 16%

Consensus revenue estimates increase by 13%

Third quarter 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.041 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.036 (vs CN¥0.067 in 2Q 2022)

Zhejiang Lante Optics Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023

New major risk - Revenue and earnings growth

Consensus revenue estimates fall by 29%

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 12% to CN¥21.94

Full year 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.35 in FY 2021)

No independent directors

Third quarter 2022 earnings released: EPS: CN¥0.041 (vs CN¥0.08 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.067 (vs CN¥0.095 in 2Q 2021)

Investor sentiment deteriorated over the past week

Price target increased to CN¥25.01

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Price target decreased to CN¥22.36

No independent directors

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.08 (vs CN¥0.16 in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.095 (vs CN¥0.09 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day low: CN¥24.16

New 90-day low: CN¥26.09

Investor sentiment deteriorated over the past week

New 90-day high: CN¥35.79

Market bids up stock over the past week

Market bids up stock over the past week

Zhejiang Lante Optics Co., Ltd. has completed an IPO in the amount of CNY 630.269 million.

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies